Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent β cell destruction in diabetic NOD mice

Transplantation

Volumn 64, Issue 7, 1997, Pages 1040-1049

  Smith, Dean K ^a   Korbutt, Gregory S ^a   Suarez Pinzon, Wilma L ^a   Kao, Dina ^a   Rajotte, Ray V ^a   Elliott, John F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GENE TRANSFER; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CYTOMEGALOVIRUS; DIABETES MELLITUS, TYPE 1; GENETIC VECTORS; GLUCOSE; GRAFT SURVIVAL; INSULIN; INTERLEUKIN-10; INTERLEUKIN-4; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TRANSPLANTATION, ISOGENEIC;

EID: 0030773969     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710150-00017     Document Type: Article

References (57)

1. Castano L, Eisenbarth GS. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990; 8: 647.
2. Stegall MD, Lafferty KJ, Kam I, Gill RG. Evidence of recurrent autoimmunity in human allogeneic islet transplantion. Transplantation 1996; 61: 1272.
3. Warnock GL, Rajotte RV. Human pancreatic islet transplantation. Transplant Rev 1992; 6: 195.
4. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992; 51: 285.
5. Wicker LS, Miller BJ, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35: 855.
6. Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T-cells form diabetic versus prediabetic NOD.NON-Thy-la donners. Diabetes 1993; 42: 44.
7. Harada M, Makino S. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy1, 2 antibody. Exp Anim 1986; 35: 501.
8. Koike T, Itoh Y, Ishii T, et al. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987; 36: 539.
9. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138.
10. H2 responses. Immunol Today 1991; 12: A49.
11. + T cells. Annu Rev Immunol 1994; 12: 635.
12. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081.
13. Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet b-cell destruction. Diabetes Rev 1993; 1: 215.
14. Debray-Sachs M, Carnaud C, Boitard C, et al. Prevention of idabetes in NOD mice treated with antibody to murine IFNg. J Autoimmun 1991; 4: 237.
15. Shehadeh NN, LaRosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 1993; 6: 291.
16. + T-cells in syngeneic islet grafts in NOD mice produce interferon-y during b-cell destruction. Diabetes 1996; 45: 1350.
17. Trinchieri G, Wysocka M, D'Andrea A, et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 1992; 4: 355.
18. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995; 181: 817.
19. Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178: 87.
20. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169.
21. Haskins K, McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990; 249: 1433.
22. Peterson JD, Haskins K. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Diabetes 1996; 45: 328.
23. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185.
24. Wogensen L, Lee M-S, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of b cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379.
25. Moritani M, Yoshimoto K, Tashiro F, et al. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 1994; 6: 1927.
26. Lee M-S, Mueller R, Wicker LS, Peterson LB, Sarvetnick N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 1996; 183: 2663.
27. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 1996; 184: 1093.
28. Becker TC, Noel RJ, Coats WS, et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 1994; 43: 161.
29. Becker TC, Noel RJ, Johnson JH, et al. Use of recombinant adenovirus vectors for high-efficiency gene transfer into the islets of Langerhans. Diabetes 1993; 42 (suppl 1): 11A.
30. Csete ME, Benhamou PY, Drazan KE, et al. Efficient gene transfer to pancreatic islets mediated by adenoviral victors. Transplantation 1995; 59: 263.
31. Csete ME, Afra R, Mullen Y, Drazan KE, Benhamou PY, Shaked A. Adenoviral-mediated gene transfer to pancreatic islets does not alter islet function. Transplant Proc 1994; 26: 756.
32. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91: 6196.
33. DeMatteo RP, Raper SE, Ahn M, et al. Gene transfer to the thymus: a means of abrogating the immune response to recombinant adenovirus. Ann Surg 1995; 222: 229.
34. Bonnerot C, Rocancourt D, Briand P, Grimber G, Nicolas J-F. A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA 1987; 84: 6795.
35. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812.
36. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802.
37. Graham FL, Prevec L. Manipulation of adenovirus vectors. Methods Mol Biol 1991; 7: 109.
38. Hitt M, Bett AJ, Addison CL, Prevec L, Graham FL. Techniques for human adenovirus vector construction and characterization. Methods Mol Genet 1995; 7: 13.
39. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988; 163: 614.
40. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59.
41. Ausubel FM. Current protocols in molecular biology. New York: John Wiley & Sons, Inc., 1995.
42. Elliott JF, Albrecht GR, Gilladoga A, et al. Genes for Plasmodium falciparum surface antigens cloned by expression in COS cells. Proc Natl Acad Sci USA 1990; 87: 6363.
43. Li L, Elliott JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 1994; 153: 3967.
44. Wang T, Singh B, Warnock GL, Rajotte RV. Prevention of recurrance of IDDM in islet transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 1992; 41: 114.
45. Korbutt GS, Pipeleers DG. Cold storage of rat pancreas before purification of islet b-cells. Diabetes 1992; 41: 299.
46. Pipeleers DG, in't Veld PA, Van De Winkel M, Maes E, Schuit FC, Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology 1985; 117: 806.
47. Pipeleers DG, Pipeleers-Marichal MA. A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 1981; 20: 654.
48. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996; 97: 2119.
49. Mosmann TR, Schumacher JH, Fiorentino DF, Leverah J, Moore KW, Bond MW. Isolation of mAbs specific for IL-4, IL-5, and IL-6 and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J Immunol 1990; 145: 2938.
50. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992; 257: 548.
51. Muruve DA, Nicolson AG, Manfro RC, Strom TB, Sukhatme VP, Libermann TA. Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. Hum Gene Ther 1997; 8: 955.
52. Michou AI, Santoro L, Christ M, Julliard V, Pavirani A, Mehtali M. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene exression. Gene Ther 1997; 4: 473.
53. Shaked A, Csete ME, Drazan KE, et al. Adenovirus-mediated gene transfer in the transplant setting. II. Sucessful expression of transferred cDNA in syngenic liver grafts. Transplantation 1994; 57: 1508.
54. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice: analysis of cytokine mRNA expression in the graft. Transplantation 1995; 60: 368.
55. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-b to inhibit macrophage cytotoxic activity. J Immunol 1992; 148: 3578.
56. Qin L, Chavin KD, Ding Y, et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation 1995; 59: 809.
57. Qin L, Chavin KD, Ding Y, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316.